Literature DB >> 17027860

The childhood limb-girdle muscular dystrophies.

Volker Straub1, Kate Bushby.   

Abstract

The heterogeneous childhood limb-girdle muscular dystrophies have originally been defined as a group of autosomal recessive and dominant diseases with progressive weakness and wasting of shoulder and pelvic-girdle muscles. Over the last 12 years, the underlying genetic defects for many of the diseases have been identified and insight into pathomechanisms of disease has been gained. At the same time, improved diagnostic techniques have allowed to extend the phenotypic spectrum for many of these devastating conditions, which showed that clinical symptoms and pathological findings are not restricted to skeletal muscles. Childhood limb-girdle muscular dystrophies are systemic diseases that often affect the musculoskeletal, respiratory, and cardiovascular system and that can go along with central nervous system involvement and gastrointestinal symptoms. The systemic nature of the diseases requires adequate management strategies that improve symptoms, longevity, and quality of life of the patients. As we are entering an era of translational research the need for precise molecular diagnoses, a thorough understanding of the natural history of the diseases and guidelines for standardized assessments of the patients become even more relevant. In this review, the best characterized childhood limb-girdle muscular dystrophies are discussed and their management aspects highlighted.

Entities:  

Mesh:

Year:  2006        PMID: 17027860     DOI: 10.1016/j.spen.2006.06.006

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  11 in total

1.  Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.

Authors:  Rui Xu; Sarah DeVries; Marybeth Camboni; Paul T Martin
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

2.  Anaesthetic Management of a Child with Limb-Girdle Muscular Dystrophy.

Authors:  Gamze Sarkılar; Aydın Mermer; Melike Yücekul; Bedia Mine Çeken; Celalettin Altun; Şeref Otelcioğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2013-06-14

3.  Myoglobinuria as first clinical sign of a primary alpha-sarcoglycanopathy.

Authors:  Ferdinando Ceravolo; Sonia Messina; Carmelo Rodolico; Pietro Strisciuglio; Daniela Concolino
Journal:  Eur J Pediatr       Date:  2013-08-30       Impact factor: 3.183

Review 4.  Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance.

Authors:  Jacques S Beckmann; Melissa Spencer
Journal:  Neuromuscul Disord       Date:  2008-10-29       Impact factor: 4.296

Review 5.  Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies.

Authors:  Volker Straub; Kate Bushby
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

6.  N-Glycolylneuraminic acid deficiency worsens cardiac and skeletal muscle pathophysiology in α-sarcoglycan-deficient mice.

Authors:  Paul T Martin; Marybeth Camboni; Rui Xu; Bethannie Golden; Kumaran Chandrasekharan; Chiou-Miin Wang; Ajit Varki; Paul M L Janssen
Journal:  Glycobiology       Date:  2013-03-20       Impact factor: 4.313

7.  Autosomal recessive limb-girdle muscular dystrophies in the Czech Republic.

Authors:  Kristýna Stehlíková; Daniela Skálová; Jana Zídková; Lenka Mrázová; Petr Vondráček; Radim Mazanec; Stanislav Voháňka; Jana Haberlová; Markéta Hermanová; Josef Zámečník; Ondřej Souček; Hana Ošlejšková; Nina Dvořáčková; Pavla Solařová; Lenka Fajkusová
Journal:  BMC Neurol       Date:  2014-08-19       Impact factor: 2.474

8.  Zebrafish models for human FKRP muscular dystrophies.

Authors:  Genri Kawahara; Jeffrey R Guyon; Yukio Nakamura; Louis M Kunkel
Journal:  Hum Mol Genet       Date:  2009-12-01       Impact factor: 6.150

9.  Molecular aging and rejuvenation of human muscle stem cells.

Authors:  Morgan E Carlson; Charlotte Suetta; Michael J Conboy; Per Aagaard; Abigail Mackey; Michael Kjaer; Irina Conboy
Journal:  EMBO Mol Med       Date:  2009-11       Impact factor: 12.137

10.  Limb Girdle Muscular Dystrophy Type 2E Due to a Novel Large Deletion in SGCB Gene.

Authors:  Soudeh Ghafouri-Fard; Feyzollah Hashemi-Gorji; Majid Fardaei; Mohammad Miryounesi
Journal:  Iran J Child Neurol       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.